|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0001675,
umls-concept:C0013216,
umls-concept:C0022341,
umls-concept:C0023418,
umls-concept:C0023449,
umls-concept:C0205195,
umls-concept:C0282460,
umls-concept:C0677874,
umls-concept:C0935989,
umls-concept:C1257890,
umls-concept:C1274040,
umls-concept:C1518321,
umls-concept:C1521828,
umls-concept:C2603343
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2006-1-19
|
|
pubmed:abstractText |
A novel therapeutic approach is urgently needed for BCR-ABL-positive acute lymphoblastic leukemia (ALL). In this study, we assessed the efficacy and feasibility of chemotherapy combined with imatinib.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
1527-7755
|
|
pubmed:author |
pubmed-author:AkiyamaHidekiH,
pubmed-author:EmiNobuhikoN,
pubmed-author:Japan Adult Leukemia Study Group,
pubmed-author:JinnaiItsuroI,
pubmed-author:KobayashiTohruT,
pubmed-author:MarutaAtsuoA,
pubmed-author:MatsuoKeitaroK,
pubmed-author:MiyawakiShuichiS,
pubmed-author:MiyazakiYasushiY,
pubmed-author:NaoeTomokiT,
pubmed-author:OhnoRyuzoR,
pubmed-author:OhtakeShigekiS,
pubmed-author:SugiuraIsamuI,
pubmed-author:TakeuchiJinJ,
pubmed-author:TakeuchiMakotoM,
pubmed-author:UedaYasunoriY,
pubmed-author:UsuiNorikoN,
pubmed-author:YagasakiFumiharuF,
pubmed-author:YanadaMasamitsuM
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
20
|
|
pubmed:volume |
24
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
460-6
|
|
pubmed:dateRevised |
2009-11-19
|
|
pubmed:meshHeading |
pubmed-meshheading:16344315-Adolescent,
pubmed-meshheading:16344315-Adult,
pubmed-meshheading:16344315-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:16344315-Feasibility Studies,
pubmed-meshheading:16344315-Female,
pubmed-meshheading:16344315-Fusion Proteins, bcr-abl,
pubmed-meshheading:16344315-Humans,
pubmed-meshheading:16344315-Japan,
pubmed-meshheading:16344315-Male,
pubmed-meshheading:16344315-Middle Aged,
pubmed-meshheading:16344315-Piperazines,
pubmed-meshheading:16344315-Precursor Cell Lymphoblastic Leukemia-Lymphoma,
pubmed-meshheading:16344315-Protein Kinase Inhibitors,
pubmed-meshheading:16344315-Protein-Tyrosine Kinases,
pubmed-meshheading:16344315-Pyrimidines,
pubmed-meshheading:16344315-Remission Induction,
pubmed-meshheading:16344315-Survival Analysis,
pubmed-meshheading:16344315-Treatment Outcome
|
|
pubmed:year |
2006
|
|
pubmed:articleTitle |
High complete remission rate and promising outcome by combination of imatinib and chemotherapy for newly diagnosed BCR-ABL-positive acute lymphoblastic leukemia: a phase II study by the Japan Adult Leukemia Study Group.
|
|
pubmed:affiliation |
Department of Hematology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan. myanada@med.nagoya-u.ac.jp
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Multicenter Study,
Clinical Trial, Phase II
|
